This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Emgality
  • /
  • Evaluation of Efficay & Safety of Galcanezumab in ...
Clinical trial

Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study (EVOLVE-2)

Read time: 3 mins
Last updated:4th Dec 2015
Identifier: NCT02614196
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest